Vaglini M - Search Results

1

Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2.

Arienti F, Belli F, Rivoltini L, Gambacorti-Passerini C, Furlan L, Mascheroni L, Prada A, Rizzi M, Marchesi E, Vaglini M, et al. Arienti F, et al. Among authors: vaglini m. Cancer Immunol Immunother. 1993 May;36(5):315-22. doi: 10.1007/BF01741170. Cancer Immunol Immunother. 1993. PMID: 8477417 Free PMC article.

2

Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan.

Vaglini M, Belli F, Ammatuna M, Inglese MG, Manzi R, Prada A, Persiani L, Santinami M, Santoro N, Cascinelli N. Vaglini M, et al. Cancer. 1994 Jan 15;73(2):483-92. doi: 10.1002/1097-0142(19940115)73:2<483::aid-cncr2820730238>3.0.co;2-s. Cancer. 1994. PMID: 8293417 Clinical Trial.

3

Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities.

Santinami M, Belli F, Cascinelli N, Rovini D, Vaglini M. Santinami M, et al. Among authors: vaglini m. J Surg Oncol. 1989 Nov;42(3):201-8. doi: 10.1002/jso.2930420315. J Surg Oncol. 1989. PMID: 2811386

4

The role of parotidectomy in the treatment of nodal metastases from cutaneous melanoma of the head and neck.

Vaglini M, Belli F, Santinami M, Cascinelli N. Vaglini M, et al. Eur J Surg Oncol. 1990 Feb;16(1):28-32. Eur J Surg Oncol. 1990. PMID: 2307240

5

Management of nodal metastases from head and neck melanoma.

Belli F, Nava M, Santinami M, Rovini D, Vaglini M. Belli F, et al. Among authors: vaglini m. J Surg Oncol. 1989 Sep;42(1):47-53. doi: 10.1002/jso.2930420111. J Surg Oncol. 1989. PMID: 2770308

6

Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanoma.

Vaglini M, Belli F, Santinami M, Arienti F, Parmiani G, Persiani L, Santoro N, Grazia Inglese M, D'Elia F, Cascinelli N. Vaglini M, et al. Ann Surg Oncol. 1995 Jan;2(1):61-70. doi: 10.1007/BF02303704. Ann Surg Oncol. 1995. PMID: 7834457

7

Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells.

Radrizzani M, Quaia M, Benedetti B, Andreola S, Vaglini M, Galligioni E, Fossati G, Parmiani G. Radrizzani M, et al. Among authors: vaglini m. Cancer Immunol Immunother. 1989;30(4):233-8. doi: 10.1007/BF01665010. Cancer Immunol Immunother. 1989. PMID: 2574630 Free PMC article.

8

Anti-melanoma monoclonal antibody 225-28S: evaluation of toxicity in man.

Cascinelli N, Attili A, Belli F, Buraggi G, Turrin A, Gasparini M, Terno G, Vaglini M. Cascinelli N, et al. Among authors: vaglini m. Tumori. 1988 Feb 29;74(1):35-40. doi: 10.1177/030089168807400106. Tumori. 1988. PMID: 3354062

9

Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-finding experience at the National Cancer Institute of Milan.

Vaglini M, Santinami M, Manzi R, Inglese MG, Santoro N, Persiani L, Belli F. Vaglini M, et al. Melanoma Res. 1994 Mar;4 Suppl 1:35-8. Melanoma Res. 1994. PMID: 8038594 Clinical Trial.

10

HLA antigens in familial and sporadic cutaneous melanoma.

Rovini D, Pellegris G, Cascinelli N, Cantoni L, Vaglini M, Placucci M, Santinami M, Belli F, Illeni MT. Rovini D, et al. Among authors: vaglini m. Tumori. 1988 Dec 31;74(6):657-64. doi: 10.1177/030089168807400607. Tumori. 1988. PMID: 3232210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters